Corporate calendar for Bolt Biotherapeutics, Inc. (BOLT): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2).
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2014-08-29 | $0.0045 | 0.50% |
| 2014-06-10 | $0.0045 | 0.50% |
| 2014-03-03 | $0.0045 | 0.50% |
| 2013-12-30 | $0.0045 | 0.50% |
| 2013-09-03 | $0.0045 | 0.50% |
| 2013-06-03 | $0.0035 | 0.39% |
| 2013-03-05 | $0.0035 | 0.39% |
| 2012-11-30 | $0.0035 | 0.39% |
| 2012-09-04 | $0.0035 | 0.39% |
| 2012-06-04 | $0.0025 | 0.28% |
Price
| Price | $3.63 |
| Market Cap | $7M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 5 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 8 |
| Avg rating (1-5) | 0.38 |
Related companies: AEON · CING · CLRB · EVGN · IMNN · INAB · LYRA
Explore sector: Healthcare · Biotechnology
More sections of BOLT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks